Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.

Gurley BJ, Swain A, Hubbard MA, Williams DK, Barone G, Hartsfield F, Tong Y, Carrier DJ, Cheboyina S, Battu SK.

Mol Nutr Food Res. 2008 Jul;52(7):755-63. doi: 10.1002/mnfr.200600300.

2.

In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.

Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Khan IA, Shah A.

Clin Pharmacol Ther. 2005 May;77(5):415-26.

3.

In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto.

Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Carrier J, Khan IA, Edwards DJ, Shah A.

Clin Pharmacol Ther. 2004 Nov;76(5):428-40. Erratum in: Clin Pharmacol Ther. 2005 May;77(5):456.

PMID:
15536458
4.
5.

Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo.

Gurley BJ, Swain A, Hubbard MA, Hartsfield F, Thaden J, Williams DK, Gentry WB, Tong Y.

Clin Pharmacol Ther. 2008 Jan;83(1):61-9. Epub 2007 May 9.

PMID:
17495878
6.

Phenotyping studies to assess the effects of phytopharmaceuticals on in vivo activity of main human cytochrome p450 enzymes.

Zadoyan G, Fuhr U.

Planta Med. 2012 Sep;78(13):1428-57. doi: 10.1055/s-0031-1298536. Epub 2012 May 15. Review.

7.
8.

Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans.

Gurley BJ, Swain A, Barone GW, Williams DK, Breen P, Yates CR, Stuart LB, Hubbard MA, Tong Y, Cheboyina S.

Drug Metab Dispos. 2007 Feb;35(2):240-5. Epub 2006 Nov 1.

9.

Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans.

Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y, Ang CY.

Clin Pharmacol Ther. 2002 Sep;72(3):276-87.

PMID:
12235448
10.

Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans.

Gurley BJ, Barone GW, Williams DK, Carrier J, Breen P, Yates CR, Song PF, Hubbard MA, Tong Y, Cheboyina S.

Drug Metab Dispos. 2006 Jan;34(1):69-74. Epub 2005 Oct 12.

11.

Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.

Markowitz JS, Donovan JL, DeVane CL, Taylor RM, Ruan Y, Wang JS, Chavin KD.

JAMA. 2003 Sep 17;290(11):1500-4.

PMID:
13129991
12.
13.

The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.

Wang Z, Gorski JC, Hamman MA, Huang SM, Lesko LJ, Hall SD.

Clin Pharmacol Ther. 2001 Oct;70(4):317-26.

PMID:
11673747
14.

Potential for interaction of kava and St. John's wort with drugs.

Singh YN.

J Ethnopharmacol. 2005 Aug 22;100(1-2):108-13. Review.

PMID:
16005588
15.

The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).

Markowitz JS, DeVane CL.

Psychopharmacol Bull. 2001 Winter;35(1):53-64. Review.

PMID:
12397870
16.

Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions.

Hermann R, von Richter O.

Planta Med. 2012 Sep;78(13):1458-77. doi: 10.1055/s-0032-1315117. Epub 2012 Aug 1. Review.

17.

Interactions between herbal medicines and prescribed drugs: a systematic review.

Izzo AA, Ernst E.

Drugs. 2001;61(15):2163-75. Review.

PMID:
11772128
18.

An ex vivo approach to botanical-drug interactions: a proof of concept study.

Wang X, Zhu HJ, Munoz J, Gurley BJ, Markowitz JS.

J Ethnopharmacol. 2015 Apr 2;163:149-56. doi: 10.1016/j.jep.2015.01.021. Epub 2015 Jan 24.

19.

Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers.

Markowitz JS, DeVane CL, Boulton DW, Carson SW, Nahas Z, Risch SC.

Life Sci. 2000 Jan 21;66(9):PL133-9.

PMID:
10698361
20.

Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements.

Sprouse AA, van Breemen RB.

Drug Metab Dispos. 2016 Feb;44(2):162-71. doi: 10.1124/dmd.115.066902. Epub 2015 Oct 5. Review.

Supplemental Content

Support Center